Intramyocardial injections of the continuous erythropoietin receptor activator (CERA) in patients with chronic ischemic cardiomyopathy. Results of the randomized study
Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.